23 July 08:20
AstraZeneca will invest 50 billion dollars to expand manufacturing and research in the US, including a new plant in Virginia for anti-obesity treatments.
Gabriel Dumitrache
International
Foto: Shutterstock
Pharmaceutical company AstraZeneca has announced a $50 billion investment in the US, aiming to expand manufacturing and research capabilities by 2030. A new facility in Virginia will produce treatments for weight and metabolic diseases, including an anti-obesity drug. This investment will create tens of thousands of jobs and reflects the company's confidence in American biopharmaceutical innovation. AstraZeneca is focusing its strategy on the U.S. market, which generated more than 40% of its revenue in 2024. The move aligns with industry trends, where other large companies are stepping up investments in the US.
Sources
AstraZeneca va investi 50 de miliarde de dolari în SUA până în 2030, pe fondul presiunilor tarifare din sectorul farmaceutic
AstraZeneca anunță că va investi 50 de miliarde de dolari în SUA până în 2030, pe fondul presiunilor tarifare
AstraZeneca va investi 50 de miliarde de dolari în SUA până în 2030, pe fondul presiunilor tarifare din sectorul farmaceutic
AstraZeneca to invest $50 bn in the US as tariff threat looms
Strategia companiilor europene pentru a-l calma pe Trump: AstraZeneca anunță o investiție masivă în SUA
AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats
AstraZeneca says to invest $50 bn in the US
AstraZeneca unveils $50bn US investment as pharma tariff threat looms - business live
AstraZeneca va investi 50 de miliarde de dolari în SUA până în 2030, pe fondul presiunilor tarifare din sectorul farmaceutic
ȘTIRI PE ACELEAȘI SUBIECTE
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
